Cervical Cancer

Models predict that near elimination of cervical cancer will be reached earlier in low-poverty versus high-poverty counties in the United States, according to a study published in Cancer Epidemiology, Biomarkers & Prevention. Jennifer C. Spencer, Ph.D., from the Harvard T. H. Chan School of Public Health in Boston, and colleagues examined the effects of human papillomavirus...

For patients with persistent, recurrent, or metastatic cervical cancer who are receiving chemotherapy with or without bevacizumab, progression-free survival and overall survival are significantly longer with pembrolizumab versus placebo, according to a study published in the New England Journal of Medicine. Nicoletta Colombo, M.D., Ph.D., from the University of Milan-Bicocca and European Institute of Oncology IRCCS,...

According to a research letter published in JAMA Network Open, a substantial proportion of women who were not vaccinated for human papillomavirus (HPV) never received cervical cancer screening or were not up to date on screening recommendations in 2019. Kalyani Sonawane, Ph.D., from UTHealth School of Public Health in Houston, and colleagues used data from the...

Following the introduction of human papillomavirus (HPV) vaccination in England, there was a substantial reduction in cervical cancer and the incidence of grade 3 cervical intraepithelial neoplasia (CIN3), according to a study published in The Lancet. Milena Falcaro, Ph.D., from King’s College London, and colleagues used an extension of the age-period-cohort Poisson model to estimate the...

Women and girls aged 15 to 24 years old have decreased cervical cancer incidence and mortality after the introduction of the human papillomavirus (HPV) vaccine, according to a research letter published in JAMA Pediatrics. Tara Tabibi, from the St. Louis University School of Medicine, and colleagues obtained national age-adjusted cervical cancer incidence and mortality data from...

According to a study published in JAMA Oncology, cervical cancer incidence varies significantly between poor and wealthy New York City neighborhoods. Stephanie Cham, M.D., from Brigham and Women’s Hospital/Dana Farber Cancer Institute in Boston, and colleagues quantified the association between neighborhood socioeconomic status (SES) and the incidence of cervical cancer in New York City (2012...

According to a study published online in JAMA Network Open, guideline-concordant cervical cancer screening rates decreased between 2005 and 2019. Ryan Suk, Ph.D., from University of Texas Health Science Center at Houston School of Public Health, and colleagues estimated changes in U.S. Preventive Services Task Force guideline-concordant cervical cancer screening over time using data from the...

Healthcare providers recommend that students receive vaccination against human papillomavirus (HPV) before entering college. Across all racial/ethnic groups, catch-up vaccination against HPV occurs at a low rate among college students. HPV vaccination is especially critical for racial/ethnic minorities, who suffer disproportionately from HPV-related cancers. Researchers conducted a study to examine the prevalence of and interest...

Young Black and Hispanic cancer patients face poorer survival odds than their white counterparts, even from some cancers that are highly curable, a new study finds. It’s well known that the United States has long-standing racial disparities in cancer survival. The researchers said the new findings bolster evidence that those disparities are not confined to...